Chemotherapy with BEACOPP may challenge ABVD as the standard of care for patients with Hodgkin's disease

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 6-6(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Bleomycin, therapeutic use; Cyclophosphamide, therapeutic use; Dacarbazine, therapeutic use; Doxorubicin, therapeutic use; Etoposide, therapeutic use; Hodgkin's-disease, treatment; Prednisone, therapeutic use; Procarbazine, therapeutic use; Vinblastine, therapeutic use; Vincristine, therapeutic use

Document Type: Research article

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$34.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A